Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

140 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Genetic determinants of telomere length and risk of pancreatic cancer: A PANDoRA study.
Campa D, Matarazzi M, Greenhalf W, Bijlsma M, Saum KU, Pasquali C, van Laarhoven H, Szentesi A, Federici F, Vodicka P, Funel N, Pezzilli R, Bueno-de-Mesquita HB, Vodickova L, Basso D, Obazee O, Hackert T, Soucek P, Cuk K, Kaiser J, Sperti C, Lovecek M, Capurso G, Mohelnikova-Duchonova B, Khaw KT, König AK, Kupcinskas J, Kaaks R, Bambi F, Archibugi L, Mambrini A, Cavestro GM, Landi S, Hegyi P, Izbicki JR, Gioffreda D, Zambon CF, Tavano F, Talar-Wojnarowska R, Jamroziak K, Key TJ, Fave GD, Strobel O, Jonaitis L, Andriulli A, Lawlor RT, Pirozzi F, Katzke V, Valsuani C, Vashist YK, Brenner H, Canzian F. Campa D, et al. Among authors: jamroziak k. Int J Cancer. 2019 Mar 15;144(6):1275-1283. doi: 10.1002/ijc.31928. Epub 2018 Nov 12. Int J Cancer. 2019. PMID: 30325019 Free article.
Carfilzomib, lenalidomide, and dexamethasone or lenalidomide alone as maintenance therapy after autologous stem-cell transplantation in patients with multiple myeloma (ATLAS): interim analysis of a randomised, open-label, phase 3 trial.
Dytfeld D, Wróbel T, Jamroziak K, Kubicki T, Robak P, Walter-Croneck A, Czyż J, Tyczyńska A, Druzd-Sitek A, Giannopoulos K, Nowicki A, Szczepaniak T, Łojko-Dankowska A, Matuszak M, Gil L, Puła B, Rybka J, Majcherek M, Usnarska-Zubkiewicz L, Szukalski Ł, Końska A, Zaucha JM, Walewski J, Mikulski D, Czabak O, Robak T, Lahoud OB, Zonder JA, Griffith K, Stefka A, Major A, Derman BA, Jakubowiak AJ. Dytfeld D, et al. Among authors: jamroziak k. Lancet Oncol. 2023 Feb;24(2):139-150. doi: 10.1016/S1470-2045(22)00738-0. Epub 2023 Jan 12. Lancet Oncol. 2023. PMID: 36642080 Free PMC article. Clinical Trial.
Clinical efficacy and tolerability of venetoclax plus rituximab in patients with relapsed or refractory chronic lymphocytic leukemia-a real-world analysis of the Polish Adult Leukemia Study Group.
Soboń A, Drozd-Sokołowska J, Paszkiewicz-Kozik E, Popławska L, Morawska M, Tryc-Szponder J, Bołkun Ł, Rybka J, Pruszczyk K, Juda A, Majeranowski A, Iskierka-Jażdżewska E, Steckiewicz P, Wdowiak K, Budziszewska B, Jamroziak K, Hus I, Lech-Marańda E, Puła B. Soboń A, et al. Among authors: jamroziak k. Ann Hematol. 2023 Aug;102(8):2119-2126. doi: 10.1007/s00277-023-05304-4. Epub 2023 Jul 1. Ann Hematol. 2023. PMID: 37392368 Free PMC article.
A Stepwise Screening Protocol for Multiple Myeloma.
Morawska M, Dwilewicz-Trojaczek J, Stompór T, Ligocki P, Stopiński M, Sutkowski M, Grząśko N, Kordecka A, Kordecki M, Jurczyszyn A, Dytfeld D, Wróbel T, Jamroziak K, Druzd-Sitek A, Walter-Croneck A, Giannopoulos K. Morawska M, et al. Among authors: jamroziak k. J Clin Med. 2023 Feb 8;12(4):1345. doi: 10.3390/jcm12041345. J Clin Med. 2023. PMID: 36835883 Free PMC article.
Analysis of Predictive Factors for Early Response to Ruxolitinib in 320 Patients with Myelofibrosis From the Polish Adult Leukemia Group (PALG) Registry.
Góra-Tybor J, Gołos A, Mikulski D, Helbig G, Sacha T, Lewandowski K, Niesiobędzka-Krężel J, Bieniaszewska M, Wysogląd H, Grzybowska-Izydorczyk O, Seferyńska I, Sobas M, Czyżewska M, Michalska A, Sawicki W, Mazur M, Hus M, Bodzenta E, Olszewska-Szopa M, Włodarczyk M, Patkowska E, Świstek W, Jamroziak K. Góra-Tybor J, et al. Among authors: jamroziak k. Clin Lymphoma Myeloma Leuk. 2023 Jan;23(1):e19-e26. doi: 10.1016/j.clml.2022.10.002. Epub 2022 Oct 22. Clin Lymphoma Myeloma Leuk. 2023. PMID: 36396583
Polyclonal immunoglobulin recovery in patients with newly diagnosed myeloma receiving maintenance therapy after autologous haematopoietic stem cell transplantation with either carfilzomib, lenalidomide and dexamethasone or lenalidomide alone: Subanalysis of the randomized phase 3 ATLAS trial.
Kubicki T, Dytfeld D, Wróbel T, Jamroziak K, Robak P, Czyż J, Tyczyńska A, Druzd-Sitek A, Giannopoulos K, Szczepaniak T, Łojko-Dankowska A, Matuszak M, Gil L, Puła B, Rybka J, Majcherek M, Usnarska-Zubkiewicz L, Szukalski Ł, Zaucha JM, Mikulski D, Czabak O, Lahoud OB, Stefka A, Derman BA, Jakubowiak AJ. Kubicki T, et al. Among authors: jamroziak k. Br J Haematol. 2023 Dec;203(5):792-802. doi: 10.1111/bjh.19097. Epub 2023 Sep 10. Br J Haematol. 2023. PMID: 37691005 Clinical Trial.
Genetics and molecular epidemiology of multiple myeloma: the rationale for the IMMEnSE consortium (review).
Martino A, Sainz J, Buda G, Jamroziak K, Reis RM, García-Sanz R, Jurado M, Ríos R, Szemraj-Rogucka Z, Marques H, Lesueur F, Moreno V, Orciuolo E, Gemignani F, Landi S, Rossi AM, Dumontet C, Petrini M, Campa D, Canzian F. Martino A, et al. Among authors: jamroziak k. Int J Oncol. 2012 Mar;40(3):625-38. doi: 10.3892/ijo.2011.1284. Epub 2011 Dec 6. Int J Oncol. 2012. PMID: 22159523 Free article. Review.
Comprehensive investigation of genetic variation in the 8q24 region and multiple myeloma risk in the IMMEnSE consortium.
Campa D, Martino A, Sainz J, Buda G, Jamroziak K, Weinhold N, Vieira Reis RM, García-Sanz R, Jurado M, Ríos R, Szemraj-Rogucka Z, Marques H, Lesueur F, Bugert P, Moreno V, Szemraj J, Orciuolo E, Gemignani F, Rossi AM, Dumontet C, Petrini M, Goldschmidt H, Landi S, Canzian F. Campa D, et al. Among authors: jamroziak k. Br J Haematol. 2012 May;157(3):331-8. doi: 10.1111/j.1365-2141.2012.09047.x. Epub 2012 Feb 13. Br J Haematol. 2012. PMID: 22590720 Free article.
Genetic susceptibility to pancreatic cancer and its functional characterisation: the PANcreatic Disease ReseArch (PANDoRA) consortium.
Campa D, Rizzato C, Capurso G, Giese N, Funel N, Greenhalf W, Soucek P, Gazouli M, Pezzilli R, Pasquali C, Talar-Wojnarowska R, Cantore M, Andriulli A, Scarpa A, Jamroziak K, Delle Fave G, Costello E, Khaw KT, Heller A, Key TJ, Theodoropoulos G, Malecka-Panas E, Mambrini A, Bambi F, Landi S, Pedrazzoli S, Bassi C, Pacetti P, Piepoli A, Tavano F, di Sebastiano P, Vodickova L, Basso D, Plebani M, Fogar P, Büchler MW, Bugert P, Vodicka P, Boggi U, Neoptolemos JP, Werner J, Canzian F. Campa D, et al. Among authors: jamroziak k. Dig Liver Dis. 2013 Feb;45(2):95-9. doi: 10.1016/j.dld.2012.09.014. Epub 2012 Dec 1. Dig Liver Dis. 2013. PMID: 23206934
Lack of replication of seven pancreatic cancer susceptibility loci identified in two Asian populations.
Campa D, Rizzato C, Bauer AS, Werner J, Capurso G, Costello E, Talar-Wojnarowska R, Jamroziak K, Pezzilli R, Gazouli M, Khaw KT, Key TJ, Bambi F, Mohelnikova-Duchonova B, Heller A, Landi S, Vodickova L, Theodoropoulos G, Bugert P, Vodicka P, Hoheisel JD, Delle Fave G, Neoptolemos JP, Soucek P, Büchler MW, Giese N, Canzian F. Campa D, et al. Among authors: jamroziak k. Cancer Epidemiol Biomarkers Prev. 2013 Feb;22(2):320-3. doi: 10.1158/1055-9965.EPI-12-1182. Epub 2012 Dec 18. Cancer Epidemiol Biomarkers Prev. 2013. PMID: 23250936
140 results